BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
HFWA
Heritage Financial Corporation
HFWA has the edge over BAC overall, supported by stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HFWA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HFWA's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HFWA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HFWA in the historical PE scenario, which offers more potential upside but is not a forecast.
HFWA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.1x | $18.36 | -35% |
| Forward | 11x | $28.21 | — |
| Fair | 14x | $27.25 | -3.4% |
| Current | 14x | $28.21 | — |
| Expensive | 18x | $35.45 | +26% |
Historical ranges are pointers, not guarantees.
HFWA's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
HFWA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HFWA, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
HFWA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.50 | +24% |
| Q3 2026 | $2.01 | +22% |
| Q2 2026 | $2.10 | +47% |
| Q1 2026 | $2.04 | +38% |
| Q4 2025 | $1.96 | +58% |
| Q3 2025 | $1.65 | +53% |
| Q2 2025 | $1.43 | +13% |
| Q1 2025 | $1.48 | +11% |
| Q4 2024 | $1.24 | -29% |
HFWA's earnings per share have fallen from their peak: $2.01 over the past year, against $2.84 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over HFWA on profitability, with a higher operating margin.
HFWA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $86.5M | +32% |
| Q2 2026 | $84.1M | +49% |
| Q1 2026 | $77.9M | +35% |
| Q4 2025 | $66.3M | +16% |
| Q3 2025 | $65.7M | +20% |
| Q2 2025 | $56.5M | +0.3% |
| Q1 2025 | $57.6M | +18% |
| Q4 2024 | $57.1M | +12% |
HFWA has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | -8.2 points |
| Q2 2026 | 25% | -1 points |
| Q1 2026 | 29% | +0.7 points |
| Q4 2025 | 39% | +10 points |
| Q3 2025 | 34% | +10 points |
| Q2 2025 | 26% | -2.8 points |
| Q1 2025 | 28% | +14 points |
| Q4 2024 | 29% | +16 points |
HFWA's operating margin was 26% last quarter, down 8.2 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HFWA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +16% |
| Q2 2026 | $21.1M | +0.9% |
| Q1 2026 | $12.7M | -30% |
| Q4 2025 | $22.3M | +12% |
| Q3 2025 | $24.4M | +5% |
| Q2 2025 | $20.9M | +250% |
| Q1 2025 | $18.1M | +51% |
| Q4 2024 | $19.8M | -34% |
HFWA has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HFWA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HFWA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -329K shares |
| 1 year | +20% | +6.8M shares |
| 3 years | +17% | +6.1M shares |
| 5 years | +15% | +5.3M shares |
| Available history | +11% | +4.2M shares |
HFWA has 41M diluted shares, up 20% from a year ago, despite $21M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10.3M |
| Q2 2026 | $10.1M |
| Q1 2026 | $960,000 |
| Q4 2025 | $44,000 |
| Q3 2025 | $24,000 |
| Q2 2025 | $4.6M |
| Q1 2025 | $838,000 |
| Q4 2024 | $4.4M |
HFWA spent $21M buying back its own shares over the past year, up 118% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HFWA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -2.9x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 4.9x | High |
HFWA has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HFWA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 45.1 | Neutral |
HFWA's weekly RSI is 50 (neutral) and its Stochastic is 45 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HFWA on valuation relative to its sector.
HFWA PE vs Financial Services Sector
| Metric | HFWA | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 7.8% above |
| PE % | 55 | 63 | 8 pts below |
HFWA is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HFWA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.2 | 0% above |
| 20 week MA | $28.9 | 2.4% below |
| 50 week MA | $27.4 | 2.9% above |
| 100 week MA | $25.5 | 10% above |
| 200 week MA | $22.8 | 24% above |
HFWA has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HFWA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.2 | $23.0 | -18% |
| 2021 | $23.0 | $24.0 | +4.4% |
| 2022 | $24.0 | $30.8 | +28% |
| 2023 | $30.8 | $21.4 | -31% |
| 2024 | $21.4 | $24.3 | +14% |
| 2025 | $24.3 | $24.5 | +0.6% |
| 2026 YTD | $24.5 | $28.2 | +15% |
HFWA has the edge over BAC on returns for 2026, with the stronger performance.